Skip to content
Screener

PP&E (Net) at other companies

Merck & Co. logo
Merck & Co.MRK
$25.74B+2.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.46B
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$18.43M+70.9%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$81.51M-16.7%
Regenxbio logo
RegenxbioRGNX
$98.45M-11.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$13.59M-27.5%

Segments

By geography

See full
US$8.18M
CN$0
GB$0

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.2B+69.1%
Enterprise value$1.11B+67.9%
P/S429.4×+416×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemJune 30, 2026December 31, 2025
Prepaid expenses and other current assets6,37720,105
Inventory1,8821,813
Total current assets188,817328,655
Property and equipment, net10,0139,023
Operating lease right-of-use assets19,84320,223
Restricted cash150150
Other assets9,3685,945
Total assets$228,191$363,996

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s PP&E (net)?
EyePoint, Inc. (EYPT) reported PP&E (net) of $10.01M in Q2 2026.
How has EyePoint, Inc.'s PP&E (net) changed year-over-year?
EyePoint, Inc.'s PP&E (net) increased by 14.3% year-over-year, from $8.76M to $10.01M.
What is the long-term trend for EyePoint, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), EyePoint, Inc.'s PP&E (net) has grown at a 70.3% compound annual growth rate (CAGR), from $630K to $9.02M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about EyePoint, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude